Found: 14
Select item for more details and to access through your institution.
Therapy With Allogeneic Severe Acute Respiratory Syndrome Coronavirus-2–Specific T Cells for Persistent Coronavirus Disease 2019 in Immunocompromised Patients.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 5, p. 696, doi. 10.1093/cid/ciad233
- By:
- Publication type:
- Article
Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS).
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e630, doi. 10.1093/cid/ciac103
- By:
- Publication type:
- Article
Severe Acute Respiratory Syndrome Coronavirus 2 Viremia Is Associated With Coronavirus Disease 2019 Severity and Predicts Clinical Outcomes.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 9, p. 1525, doi. 10.1093/cid/ciab686
- By:
- Publication type:
- Article
Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA in Blood of Patients With Coronavirus Disease 2019 (COVID-19): What Does It Mean?
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 9, p. e2898, doi. 10.1093/cid/ciaa1316
- By:
- Publication type:
- Article
Prospective Assessment of Humoral and Cellular Immune Responses to a Third COVID-19 mRNA Vaccine Dose Among Immunocompromised Individuals.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 5, p. 1328, doi. 10.1093/infdis/jiad511
- By:
- Publication type:
- Article
Plasma SARS-CoV-2 RNA Levels as a Biomarker of Lower Respiratory Tract SARS-CoV-2 Infection in Critically Ill Patients With COVID-19.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 12, p. 2089, doi. 10.1093/infdis/jiac157
- By:
- Publication type:
- Article
Contribution of Coronavirus-Specific Immunoglobulin G Responses to Complement Overactivation in Patients with Severe Coronavirus Disease 2019.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 5, p. 766, doi. 10.1093/infdis/jiac091
- By:
- Publication type:
- Article
Rapid Emergence of Potentially Transmissible Severe Acute Respiratory Syndrome Coronavirus 2 With Resistance to Combination Monoclonal Antibody Therapy.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Persistent HIV-1 Viremia on Antiretroviral Therapy: Measurement and Mechanisms.
- Published in:
- Frontiers in Microbiology, 2019, p. 1, doi. 10.3389/fmicb.2019.02383
- By:
- Publication type:
- Article
SARS-CoV-2 variants of concern: spike protein mutational analysis and epitope for broad neutralization.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32262-8
- By:
- Publication type:
- Article
HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virus.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance.
- Published in:
- 2019
- By:
- Publication type:
- journal article
TIM-3 signaling contributes to the suppressive capacity of Tregs from people with HIV on antiretroviral therapy.
- Published in:
- Journal of Leukocyte Biology, 2023, v. 114, n. 4, p. 368, doi. 10.1093/jleuko/qiad068
- By:
- Publication type:
- Article
Tracking HIV-1-Infected Cell Clones Using Integration Site-Specific qPCR.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 7, p. 1235, doi. 10.3390/v13071235
- By:
- Publication type:
- Article